Latest Breaking News On - பாஸ்காம் பாமர் கண் நிறுவனம் - Page 1 : comparemela.com

Scientists use mice in promising glaucoma gene therapy study Published:  Research on gene therapy for glaucoma shows promise MIAMI, Fla. – Glaucoma is the second leading cause of blindness worldwide, resulting from irreversible loss of function of the optic nerve. A recent study, supported by the National Eye Institute, found a form of gene therapy which could protect and preserve optic nerve cells in studies using mice. “It’s an impressive finding. It’s in a high profile journal, however, these are studies in mice,” said Dr. Richard Lee with Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. “And we’re a little larger than mice in general so it has yet to be translated into clinical studies in humans. It is a good proof of principal especially since the vectors they used to give these genes into the cells are similar to the ones that we use currently in gene therapy studies,” Lee said.

United statesRichard leeHeart healthNational eye instituteBascom palmer eye instituteUniversity of miami miller school medicineMiami miller schoolஒன்றுபட்டது மாநிலங்களில்ரிச்சர்ட் லீஇதயம் ஆரோக்கியம்தேசிய கண் நிறுவனம்பாஸ்காம் பாமர் கண் நிறுவனம்பல்கலைக்கழகம் ஆஃப் மியாமி மில்லர் பள்ளி மருந்துமியாமி மில்லர் பள்ளி